From: Control of hypertension in the critically ill: a pathophysiological approach
 | Heart rate | Myocardial contractility | Preload | Systemic vascular resistance |
---|---|---|---|---|
Nitrates | Â | Â | Â | Â |
Nitroglycerin | + | 0 | _ _ | _ |
Nitroprusside | + | 0 | _ _ | _ _ |
Hydralazine | +/++ | 0 | 0/+ | _ _ _ |
ACE inhibitors and AT1 receptor blockers | 0 | 0 | _ | _ _ _ |
Calcium channel blockers | Â | Â | Â | Â |
Amlodipine | _ | _ | 0 | ++ |
Nifedipine | _ | _ | 0 | + + + |
Nicardipine | 0 | _ | 0 | +++ |
Diltiazem | _ _ | _ | 0 | + |
β−blockers | _ _ _ | _ _ | 0 | + |
β-blockers with intrinsic | _ | _ | 0 | 0/_ |
sympathomimetic activity | Â | Â | Â | Â |
Phentolamine | 0/ _ | _ | 0/+ | _ _ _ |
Urapidil | 0/+ | 0 | _ _ | _ _ _ |
Diuretics | 0/+ | 0 | _ _ _ | + + |
Clonidine | _ _ | 0 | 0 | _ _ |
Methyldopa | 0/ _ | 0/ _ | 0/ + | _ _ |